Source:http://linkedlifedata.com/resource/pubmed/id/12746699
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2-3 Pt 2
|
pubmed:dateCreated |
2003-5-14
|
pubmed:abstractText |
Spasticity is one of the clinical signs observed after a lesion of the pyramidal tract. Clinical manifestations are polymorphous and depend on the location of the lesion on the pre-motoneuron. Functional consequences are also variable. Only negative effects such as painful spasms, stiffness, distortions, are to be treated. Three different categories of drugs are available: GABA-like (baclofen, benzodiazepine), central alpha 2 agonists (tizanidine, clonidine) and peripheral anti-spastics (dantrolene). Baclofen remains the most commonly used anti-spastic. The preferential indication is spasticity from spinal cord disease, especially when the aetiology is multiple sclerosis. Efficacy of benzodiazepines (diazepam, tetrazepam, clonazepam) is comparable with baclofen; however, side effects (drowsiness) are more frequent. Benzodiazepines are indicated when spasticity is associated with anxiety. Tizanidine is an efficient and well tolerated antispastic. In France, prescription requires a temporary authorization of use. Dantrolen has a peripheral mechanism of action and can be prescribed in the different forms of spasticity. There are other compounds with anti-spastic properties (gabapentine, cyproheptadine, piracetam). Their advantage is rather limited when used alone. Generally, they are administrated in combinaison with usual anti-spastic drugs.
|
pubmed:language |
fre
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0028-3770
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
49
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
247-55
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:12746699-Adrenergic alpha-Agonists,
pubmed-meshheading:12746699-GABA Agonists,
pubmed-meshheading:12746699-Humans,
pubmed-meshheading:12746699-Muscle Relaxants, Central,
pubmed-meshheading:12746699-Muscle Spasticity,
pubmed-meshheading:12746699-Neuromuscular Agents,
pubmed-meshheading:12746699-Spinal Cord
|
pubmed:year |
2003
|
pubmed:articleTitle |
[Medical treatment of spasticity].
|
pubmed:affiliation |
Service de Rééducation Neurologique, Hôpital Henry-Gabrielle, Hospices Civils de Lyon et Université Cl.-Bernard Lyon-I.
|
pubmed:publicationType |
Journal Article,
English Abstract,
Review
|